FGF8 Gene

Migration, Crosslink

📖

FGF8 Gene

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-fgf8

📖 Wiki Page

gene2232 wordssynced 2026-04-02

FGF8 Gene

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">FGF8</th></tr>
<tr><td>Full Name</td><td>Fibroblast Growth Factor 8</td></tr>
<tr><td>Chromosomal Location</td><td>10q24.33</td></tr>
<tr><td>NCBI Gene ID</td><td>[2253](https://www.ncbi.nlm.nih.gov/gene/2253)</td></tr>
<tr><td>OMIM</td><td>[600483](https://www.omim.org/entry/600483)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000107882</td></tr>
<tr><td>UniProt</td><td>[P55075](https://www.uniprot.org/uniprot/P55075)</td></tr>
<tr><td>Protein Size</td><td>215 amino acids (24 kDa)</td></tr>
<tr><td>Expression</td><td>Brain (frontal cortex, hippocampus), substantia nigra, hypothalamus, SVZ</td></tr>
<tr><td>Associated Diseases</td><td>Parkinson's Disease, Alzheimer's Disease, Autism Spectrum Disorder, Schizophrenia, Kallmann Syndrome</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Overview

...

FGF8 Gene

Gene Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">FGF8</th></tr>
<tr><td>Full Name</td><td>Fibroblast Growth Factor 8</td></tr>
<tr><td>Chromosomal Location</td><td>10q24.33</td></tr>
<tr><td>NCBI Gene ID</td><td>[2253](https://www.ncbi.nlm.nih.gov/gene/2253)</td></tr>
<tr><td>OMIM</td><td>[600483](https://www.omim.org/entry/600483)</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000107882</td></tr>
<tr><td>UniProt</td><td>[P55075](https://www.uniprot.org/uniprot/P55075)</td></tr>
<tr><td>Protein Size</td><td>215 amino acids (24 kDa)</td></tr>
<tr><td>Expression</td><td>Brain (frontal cortex, hippocampus), substantia nigra, hypothalamus, SVZ</td></tr>
<tr><td>Associated Diseases</td><td>Parkinson's Disease, Alzheimer's Disease, Autism Spectrum Disorder, Schizophrenia, Kallmann Syndrome</td></tr>
</table>
</div>

Pathway / Interaction Diagram

Mermaid diagram (expand to render)

Overview

FGF8 (Fibroblast Growth Factor 8) encodes a critical signaling molecule belonging to the FGF family of heparin-binding growth factors. Originally identified as an androgen-induced growth factor, FGF8 plays essential roles in embryonic development, tissue patterning, and cellular proliferation during early development [@fgf1998]. In the adult brain, FGF8 continues to serve vital functions in neurogenesis, synaptic plasticity, neural repair, and the maintenance of dopaminergic neurons [@fgf2015].

FGF8 exerts its effects through binding to fibroblast growth factor receptors (FGFRs), particularly FGFR1 and FGFR2, initiating intracellular signaling cascades that regulate gene expression, cell survival, proliferation, and differentiation. The unique expression pattern of FGF8 in key brain regions, including the substantia nigra, hippocampus, and subventricular zone, positions it as a molecule of significant interest in neurodegenerative disease research [@fgf2018].

This page provides comprehensive coverage of FGF8's normal physiological functions, its roles in various neurological disorders, expression patterns throughout the brain, and the therapeutic implications of FGF8 signaling modulation.

Protein Structure and Biochemistry

FGF8 is a member of the FGF family, which comprises 22 related growth factors in humans that share a conserved β-trefoil fold structure. Understanding the molecular architecture of FGF8 provides insight into its biological functions and therapeutic potential.

Structural Features

The FGF8 protein (215 amino acids, ~24 kDa) possesses the characteristic structural features of the FGF family:

Core β-Trefoil Domain:
The three-dimensional structure of FGF8 centers on a β-trefoil fold composed of 12 β-strands arranged in four β-sheets. This highly conserved fold creates a binding interface for fibroblast growth factor receptors (FGFRs) and mediates interactions with heparan sulfate proteoglycans (HSPGs) on the cell surface [@fgf2020b].

Heparin-Binding Site:
Located on the surface of the β-trefoil domain, the heparin-binding site consists of positively charged residues that interact with heparan sulfate chains. This interaction is essential for:

Stabilizing FGF8 in the extracellular space
Presenting FGF8 to its receptors
Preventing proteolytic degradation
Facilitating gradient formation during development

Receptor-Binding Interface:
The receptor-binding surface of FGF8 engages the immunoglobulin-like domains (D2 and D3) of FGFRs. The specificity of FGF8 for particular FGFRs is determined by subtle variations in this interface [@fgf2020b].

Isoforms and Variants

FGF8 exhibits alternative splicing that generates multiple isoforms with distinct biological activities [@fgf2011]:

Major Isoforms:

FGF8a: The most common isoform, widely expressed during development
FGF8b: More potent in certain contexts, particularly in neural specification
FGF8c/d/e/f: Less characterized isoforms with tissue-specific expression

The relative abundance of these isoforms varies across brain regions and developmental stages, adding another layer of complexity to FGF8 signaling.

Cellular Functions

FGF8 exerts diverse cellular effects through activation of FGFR signaling pathways. The downstream consequences of FGF8 signaling encompass multiple aspects of neuronal biology.

Neurogenesis and Neural Progenitor Cell Regulation

FGF8 is a critical regulator of neural stem cell proliferation and differentiation in both embryonic and adult brains [@fgf2021]:

Embryonic Neurogenesis:
During cortical development, FGF8 acts as a patterning factor that specifies regional identity and promotes progenitor proliferation. It works in concert with other morphogens (BMPs, Wnts, Shh) to establish the anterior-posterior and dorsal-ventral axes of the developing neural tube.

Adult Neurogenesis:
In the adult mammalian brain, FGF8 continues to be expressed in the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus, where it maintains the neural stem cell niche [@fgf2015]:

FGF8 promotes proliferation of neural progenitor cells
It supports survival of newly generated neurons
It influences neuronal differentiation toward specific phenotypes

Dopaminergic Neuron Development and Maintenance

A particularly important function of FGF8 relates to dopaminergic (DA) neurons of the substantia nigra pars compacta (SNc), which degenerate in Parkinson's disease [@fgf2019]:

Developmental Role:
FGF8 is expressed in the midbrain during embryonic development and participates in the specification and survival of DA neuron precursors. It acts as a trophic factor that promotes:

Mesencephalic DA neuron proliferation
Differentiation toward the dopaminergic phenotype
Axon guidance and target innervation

Maintenance and Repair:
In the adult brain, FGF8 continues to support DA neuron survival and may participate in compensatory repair mechanisms [@fgf2018]:

FGF8 expression is detected in the substantia nigra of adult rodents
Exogenous FGF8 can protect DA neurons in toxin-based PD models
FGF8 promotes neurite outgrowth and dopamine release

Synaptic Plasticity and Neuroprotection

FGF8 influences synaptic function and provides neuroprotective effects [@fgf2022]:

Synaptic Effects:

Modulation of excitatory glutamatergic transmission
Regulation of synaptic vesicle dynamics
Influence on long-term potentiation (LTP) in the hippocampus
Promotion of dendritic spine formation

Neuroprotective Mechanisms:
FGF8 activates pro-survival signaling cascades that protect neurons from various insults [@fgf2023]:

PI3K/Akt pathway activation promotes cell survival
MAPK/ERK signaling supports neuronal differentiation
FGF8 can reduce oxidative stress-induced damage
Anti-apoptotic effects through Bcl-2 family proteins

Signaling Mechanisms

FGF8 signaling involves a sophisticated cascade of molecular events that translate extracellular signals into cellular responses.

Receptor Interactions

FGF8 binds to multiple fibroblast growth factor receptors with distinct specificities [@fgf2020b]:

Primary Receptors:

FGFR1: Highest affinity for FGF8, widely expressed in the brain
FGFR2: Expressed in neural progenitors and certain neuronal populations

Alternative Receptors:

FGFR3: Lower affinity, expression in specific brain regions
FGFR4: Limited brain expression, primarily in non-neural tissues

Co-receptor Requirement:
Heparan sulfate proteoglycans (HSPGs) such as syndecans and glypicans are required for efficient FGF8-FGFR interaction. They serve as " presenters" that cluster receptors and enhance signaling.

Intracellular Signaling Pathways

Upon FGFR activation, FGF8 triggers multiple downstream signaling cascades:

RAS/MAPK Pathway:
The primary pathway activated by FGFRs, leading to:

RAF/MEK/ERK activation
Gene transcription through ELK-1, c-Fos
Cell proliferation and differentiation

PI3K/AKT Pathway:
A pro-survival pathway that:

Inhibits apoptosis through BAD phosphorylation
Supports metabolic regulation
Promotes protein synthesis via mTOR

PLCγ Pathway:
Phospholipase C gamma activation leads to:

Calcium release from intracellular stores
PKC activation
Modulation of cytoskeletal dynamics

Signal Termination

FGF8 signaling is carefully regulated to prevent excessive or inappropriate activation:

FGF8 expression is regulated at transcriptional and post-transcriptional levels
Receptor internalization removes activated receptors from the cell surface
Sprouty proteins provide negative feedback on MAPK signaling
FGFR degradation through lysosomal pathways terminates signaling

Disease Associations

FGF8 has been implicated in several neurological disorders, reflecting its essential roles in brain development and function.

Parkinson's Disease

FGF8 is of particular interest in Parkinson's disease (PD) research due to its roles in dopaminergic neuron biology [@fgf2018]:

Altered Expression in PD:

FGF8 mRNA and protein levels are reduced in the substantia nigra of PD patients
Expression changes correlate with disease severity
Decreased FGF8 may contribute to reduced neuroplasticity in PD brains

Therapeutic Potential:

FGF8 administration protects dopaminergic neurons in MPTP and 6-OHDA models
Gene therapy approaches using FGF8 have shown promise in preclinical studies
FGF8 combined with other neurotrophic factors (GDNF, BDNF) produces synergistic effects

Mechanisms of Protection:

Promotion of dopamine synthesis through tyrosine hydroxylase regulation
Enhancement of neuronal survival pathways
Support for axonal regeneration
Reduction of neuroinflammation

Alzheimer's Disease

FGF8 is also implicated in Alzheimer's disease (AD) pathogenesis [@fgf2023]:

Expression Alterations:

FGF8 expression changes in AD-affected brain regions
Altered signaling may contribute to neurogenesis impairment
Interactions with amyloid pathology have been reported

Therapeutic Implications:

FGF8 may support hippocampal neurogenesis impaired in AD
Neuroprotective effects could benefit cholinergic neurons
Combination approaches with other growth factors are being explored

Autism Spectrum Disorder and Schizophrenia

FGF8 plays critical roles in brain development, and dysregulation contributes to neurodevelopmental disorders [@fgf2016]:

Autism Spectrum Disorder (ASD):

FGF8 mutations are associated with ASD
Altered FGF8 signaling affects cortical development
Social behavior deficits in FGF8-deficient mouse models

Schizophrenia:

FGF8 expression abnormalities in prefrontal cortex
Implicated in developmental abnormalities observed in schizophrenia
May affect synaptic pruning and circuit refinement

Kallmann Syndrome

FGF8 mutations cause hypogonadotropic hypogonadism with anosmia (Kallmann syndrome) [@fgf2013]:

FGF8 is required for olfactory bulb development
Mutations disrupt gonadotropin-releasing hormone (GnRH) neuron migration
FGF8 haploinsufficiency causes the reproductive phenotype

Expression Pattern

FGF8 exhibits distinctive expression patterns that inform its biological functions.

Developmental Expression

During embryonic development, FGF8 is expressed in dynamic patterns [@fgf2014]:

Brain Regions:

Anterior neural plate and forebrain
Midbrain-hindbrain boundary (isthmus)
Hypothalamic regions
Cortical primordium

Temporal Pattern:

Highest expression during mid-gestation
Gradual decline toward birth
Continued expression in specific regions postnatally

Adult Brain Expression

In the adult brain, FGF8 expression is more restricted [@fgf2015]:

High Expression Regions:

Subventricular zone (SVZ): Neural stem cell niche
Hippocampus: Dentate gyrus and CA regions
Hypothalamus: Paraventricular and arcuate nuclei
Substantia nigra: Pars compacta and reticulata
Cerebral cortex: Layer-specific expression

Cellular Localization:

Predominantly in neurons
Some expression in astrocytes
Low or absent in microglia under normal conditions

Regulation of Expression

FGF8 expression is subject to multiple regulatory mechanisms:

Transcriptional Regulation:

Developmental transcription factors (Otx2, Pax6)
Activity-dependent mechanisms
Epigenetic modifications

Post-Transcriptional Regulation:

Alternative splicing generates multiple isoforms
MicroRNA-mediated repression
RNA-binding protein control

Activity-Dependent Regulation:

Neuronal activity modulates FGF8 expression
Immediate-early gene induction
Calcium-dependent pathways

Therapeutic Implications

FGF8 signaling represents a potential therapeutic target for neurodegenerative diseases.

Neurotrophic Factor Therapy

FGF8 shares properties with other neurotrophic factors being developed for PD and AD:

Advantages:

Supports dopaminergic neuron survival
Promotes neurogenesis
Provides neuroprotection across multiple neuronal types

Challenges:

Delivery to the brain is difficult
Optimal dosing and timing uncertain
Potential for off-target effects

Delivery Strategies

Multiple approaches are being explored for FGF8 delivery:

Protein Delivery:

Direct protein administration
Encapsulated cell approaches
Modified peptides with enhanced brain penetration

Gene Therapy:

Viral vector-mediated expression (AAV, lentivirus)
Non-viral approaches (liposomes, nanoparticles)
Cell-based delivery using engineered cells

Small Molecule Agonists:

FGFR-activating compounds
Positive allosteric modulators
Development ongoing

Combination Approaches

FGF8 may be most effective in combination with other therapeutic agents:

FGF8 + GDNF: Synergistic dopaminergic protection
FGF8 + BDNF: Enhanced neurogenesis
FGF8 + small molecules: Optimized delivery and efficacy

Key Publications

[@fgf2020] FGF8 in brain development and disease. Neuron (2020)

[@fgf2019] FGF8 and dopaminergic neuron development. Cell Mol Neurobiol (2019)

[@fgf2021] FGF signaling in neurogenesis. Trends Neurosci (2021)

[@fgf1998] FGF8 mutation causes aperture syndrome. Nat Genet (1998)

[@fgf2015] FGF8 in adult neurogenesis and brain repair. Prog Neurobiol (2015)

[@fgf2018] FGF8 and Parkinson's disease models. J Parkinsons Dis (2018)

[@fgf2022] FGF8 signaling in synaptic plasticity. Nat Rev Neurosci (2022)

[@fgf2016] FGF8 in psychiatric disorders. Mol Psychiatry (2016)

Cross-References

[FGF20](/genes/fgf20) - Related FGF family member
[FGFR1](/genes/fgfr1) - FGF receptor
[Neurogenesis Pathway](/mechanisms/neurogenesis) - Pathway
[Parkinson's Disease](/diseases/parkinsons-disease) - Disease
[Substantia Nigra](/brain-regions/substantia-nigra) - Brain region

External Links

[NCBI Gene: FGF8](https://www.ncbi.nlm.nih.gov/gene/2253)
[Ensembl: ENSG00000107882](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107882)
[UniProt: P55075](https://www.uniprot.org/uniprot/P55075)
[GeneCards: FGF8](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF8)
[OMIM: 600483](https://omim.org/entry/600483)
[Allen Brain Atlas: FGF8](https://human.brain-map.org/microarray/search/show?search_term=FGF8)

References

[Unknown, FGF8 in brain development and disease. Neuron (2020)](https://doi.org/10.1016/j.neuron.2020.04.015)

[Unknown, FGF8 and dopaminergic neuron development. Cell Mol Neurobiol (2019)](https://doi.org/10.1007/s12035-019-01678-5)

[Unknown, FGF signaling in neurogenesis. Trends Neurosci (2021)](https://doi.org/10.1016/j.tins.2021.02.003)

Function

FGF8 is a key member of the FGF family:

Development

Brain Development: Essential for forebrain and midbrain patterning
Limb Development: Critical for limb bud formation
Gonad Development: Important for testis development and function
Neural Progenitor Proliferation: Regulates stem cell pools

Adult Brain Function

Neurogenesis: Supports hippocampal and subventricular zone neurogenesis
Synaptic Plasticity: Modulates excitatory synaptic transmission
Neuronal Survival: Neuroprotective effects
Response to Injury: Involved in neural repair mechanisms

Signaling Mechanisms

FGF8 signals through:

FGFR1: Primary receptor
FGFR2: Secondary receptor
FGFR3: Alternative receptor
FGFR4: Some contexts

Heparan sulfate proteoglycans are required for signaling.

Disease Associations

Parkinson's Disease

FGF8 involvement in PD:

Altered FGF8 expression in PD substantia nigra
FGF8 promotes dopaminergic neuron survival
Neuroprotective effects in PD models
May support neural repair

Autism Spectrum Disorder

FGF8 mutations associated with ASD
Critical for social behavior development
Altered brain connectivity

Schizophrenia

Dysregulated FGF8 signaling in schizophrenia
Abnormal brain development associations
Cognitive dysfunction

Hypogonadotropic Hypogonadism

FGF8 mutations cause Kallmann syndrome
Olfactory bulb development
Gonadotropin release

Expression

FGF8 exhibits specific expression patterns:

Developing Brain: High expression in forebrain
Adult Brain: Moderate expression in [hippocampus](/brain-regions/hippocampus)
Subventricular Zone: Neural progenitor expression
Hypothalamus: Neuroendocrine expression
Testis: High expression in Leydig cells

Expression is regulated by:

Androgens
Developmental signals
Neural activity

Key Publications

[FGF8 in brain development and disease (2020)](https://doi.org/10.1016/j.neuron.2020.04.015)

[FGF8 and dopaminergic neuron development (2019)](https://doi.org/10.1007/s12035-019-01678-5)

[FGF signaling in neurogenesis (2021)](https://doi.org/10.1016/j.tins.2021.02.003)

Cross-References

[FGF20](/genes/fgf20) - Related FGF family member
[FGFR1](/genes/fgfr1) - FGF receptor
[Neurogenesis Pathway](/mechanisms/neurogenesis) - Pathway

External Links

[NCBI Gene: FGF20](https://www.ncbi.nlm.nih.gov/gene/2253)
[Ensembl: ENSG00000107882](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107882)
[UniProt: P55075](https://www.uniprot.org/uniprot/P55075)
[GeneCards: FGF20](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF20)
[OMIM: FGF20](https://omim.org/search?search=FGF20)
[Allen Brain Atlas: FGF20](https://human.brain-map.org/microarray/search/show?search_term=FGF20)

References

[Unknown, FGF8 in brain development and disease. Neuron (2020) (2020)](https://doi.org/10.1016/j.neuron.2020.04.015)

[Unknown, FGF8 and dopaminergic neuron development. Cell Mol Neurobiol (2019) (2019)](https://doi.org/10.1007/s12035-019-01678-5)

[Unknown, FGF signaling in neurogenesis. Trends Neurosci (2021) (2021)](https://doi.org/10.1016/j.tins.2021.02.003)

Pathway Diagram

The following diagram shows the key molecular relationships involving FGF8 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

FGF8

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-fgf8
kg_node_id	FGF8
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-93b1480572b6
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-fgf8'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

28

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

FGF8 Gene

FGF8 Gene

Gene Overview

Pathway / Interaction Diagram

Overview

FGF8 Gene

Gene Overview

Pathway / Interaction Diagram

Overview

Protein Structure and Biochemistry

Structural Features

Isoforms and Variants

Cellular Functions

Neurogenesis and Neural Progenitor Cell Regulation

Dopaminergic Neuron Development and Maintenance

Synaptic Plasticity and Neuroprotection

Signaling Mechanisms

Receptor Interactions

Intracellular Signaling Pathways

Signal Termination

Disease Associations

Parkinson's Disease

Alzheimer's Disease

Autism Spectrum Disorder and Schizophrenia

Kallmann Syndrome

Expression Pattern

Developmental Expression

Adult Brain Expression

Regulation of Expression

Therapeutic Implications

Neurotrophic Factor Therapy

Delivery Strategies

Combination Approaches

Key Publications

Cross-References

See Also

External Links

References

Function

Development

Adult Brain Function

Signaling Mechanisms

Disease Associations

Parkinson's Disease

Autism Spectrum Disorder

Schizophrenia

Hypogonadotropic Hypogonadism

Expression

Key Publications

Cross-References

See Also

External Links

References

Pathway Diagram

💬 Discussion